• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life

tetano

Editor, Senior Moderator
J Immunol. 2015 Apr 13. pii: 1402071. [Epub ahead of print]
[h=1]MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life.[/h] Mastelic Gavillet B[SUP]1[/SUP], Eberhardt CS[SUP]1[/SUP], Auderset F[SUP]1[/SUP], Castellino F[SUP]2[/SUP], Seubert A[SUP]2[/SUP], Tregoning JS[SUP]3[/SUP], Lambert PH[SUP]1[/SUP], de Gregorio E[SUP]2[/SUP], Del Giudice G[SUP]2[/SUP], Siegrist CA[SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The early life influenza disease burden calls for more effective vaccines to protect this vulnerable population. Influenza vaccines including the MF59 oil-in-water adjuvant induce higher, broader, and more persistent Ab responses in adults and particularly in young, through yet undefined mechanisms. In this study, we show that MF59 enhances adult murine IgG responses to influenza hemagglutinin (HA) by promoting a potent T follicular helper cells (T[SUB]FH[/SUB]) response, which directly controls the magnitude of the germinal center (GC) B cell response. Remarkably, this enhancement of T[SUB]FH[/SUB] and GC B cells is already fully functional in 3-wk-old infant mice, which were fully protected by HA/MF59 but not HA/PBS immunization against intranasal challenge with the homologous H1N1 (A/California/7/2009) strain. In 1-wk-old neonatal mice, MF59 recruits and activates APCs, efficiently induces CD4[SUP]+[/SUP] effector T cells and primes for enhanced infant responses but induces few fully functional T[SUB]FH[/SUB] cells, which are mostly follicular regulatory T cells, and poor GC and anti-HA responses. The B cell adjuvanticity of MF59 appears to be mediated by the potent induction of T[SUB]FH[/SUB] cells which directly controls GC responses both in adult and early life, calling for studies assessing its capacity to enhance the efficacy of influenza immunization in young infants.
Copyright ? 2015 by The American Association of Immunologists, Inc.


PMID: 25870238 [PubMed - as supplied by publisher]
 
Back
Top Bottom